Trials / Completed
CompletedNCT00023361
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 215 (planned)
- Sponsor
- Centers for Disease Control and Prevention · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: To determine the rate of confirmed treatment failure and relapse with an intermittent rifabutin-based regimen for the treatment of isoniazid and rifamycin-susceptible HIV-related tuberculosis (TB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rifabutin |
Timeline
- Start date
- 1999-02-01
- Completion
- 2003-02-01
- First posted
- 2001-09-10
- Last updated
- 2005-09-05
Locations
23 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00023361. Inclusion in this directory is not an endorsement.